Add to ORKGTau clearance mechanisms and their possible role in the pathogenesis of Alzheimer diseas
ABSTRACT: Alzheimers disease (AD) is a heterogeneous group of dementias characterized by progressive...
One of the most commonly known chronic neurodegenerative disorders, Alzheimer’s disease (AD), ...
Alzheimer's disease (AD) is characterized by the presence of two aberrant structures: namely senile ...
One of the defining pathological features of Alzheimer disease (AD) is the intraneuronal accumulatio...
Amyloid-β peptide (Aβ) and tau protein deposits in the human brain are the pathological ha...
Alzheimer's disease (AD) and related dementias constitute a major public health issue due to an incr...
Alzheimer’s disease (AD) is the leading cause of dementia in elderly people. Amyloid beta (Aβ) depos...
Copyright © 2012 Michala Kolarova et al. This is an open access article distributed under the Creati...
The microtubule-associated protein (MAP) tau plays a critical role in the pathogenesis of Alzheimer’...
Tau aggregation is a hallmark of several neurodegenerative diseases, including AD (Alzheimer’s disea...
Sporadic Alzheimer’s Disease (AD) is the most common form of dementia, and its severity is character...
Many hypotheses have been raised regarding the pathophysiology of Alzheimer’s disease (AD). Because ...
Tau is a protein that associates with microtubules (MTs) and promotes their assembly and stability. ...
Fibrillar deposits of highly phosphorylated tau are a key pathological feature of several neurodegen...
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder and the most common type of dementi...
ABSTRACT: Alzheimers disease (AD) is a heterogeneous group of dementias characterized by progressive...
One of the most commonly known chronic neurodegenerative disorders, Alzheimer’s disease (AD), ...
Alzheimer's disease (AD) is characterized by the presence of two aberrant structures: namely senile ...
One of the defining pathological features of Alzheimer disease (AD) is the intraneuronal accumulatio...
Amyloid-β peptide (Aβ) and tau protein deposits in the human brain are the pathological ha...
Alzheimer's disease (AD) and related dementias constitute a major public health issue due to an incr...
Alzheimer’s disease (AD) is the leading cause of dementia in elderly people. Amyloid beta (Aβ) depos...
Copyright © 2012 Michala Kolarova et al. This is an open access article distributed under the Creati...
The microtubule-associated protein (MAP) tau plays a critical role in the pathogenesis of Alzheimer’...
Tau aggregation is a hallmark of several neurodegenerative diseases, including AD (Alzheimer’s disea...
Sporadic Alzheimer’s Disease (AD) is the most common form of dementia, and its severity is character...
Many hypotheses have been raised regarding the pathophysiology of Alzheimer’s disease (AD). Because ...
Tau is a protein that associates with microtubules (MTs) and promotes their assembly and stability. ...
Fibrillar deposits of highly phosphorylated tau are a key pathological feature of several neurodegen...
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder and the most common type of dementi...
ABSTRACT: Alzheimers disease (AD) is a heterogeneous group of dementias characterized by progressive...
One of the most commonly known chronic neurodegenerative disorders, Alzheimer’s disease (AD), ...
Alzheimer's disease (AD) is characterized by the presence of two aberrant structures: namely senile ...